Drawing for ORBUS PHARMA

USPTO serial 78828906

ORBUS PHARMA

Reviewed by CopyMark Law Group

Reg. 3669440Status 710
Filing date
Status date
Registration date
Aug 18, 2009
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ORBUS PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey D. Myers

JEFFREY D MYERS PEACOCK MYERS PCPO BOX 26927ALBUQUERQUE, NM 87125-6927UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biological and diagnostic reagents for scientific and research use; chemicals all for use in the manufacture of pharmaceutical preparations for human use, namely, drug precursors, excipients, dispersants, granulating agents, lubricants and opacifiersSECTION 8 - CANCELLED—
005Pharmaceutical preparations for human use, namely, anti-epileptics, antibiotics, anti-hypertensives, anti-hypercholesterolemic, anti-hyperlipidemias, beta-adrenoreceptor antagonists, anti-depressants, anti-virals, anti-platelets, adrenocorticals, analgesics, anaphylactics, anti-anginals, anti-arthritics, anti-inflammatories, antihistamines, antipsychotics, gastrointestinal preparations, hormonal preparations, respiratory preparations, steroid preparations and vaccines; nutritional supplements; vitaminsSECTION 8 - CANCELLED—
040Manufacturing of pharmaceuticals to order and/or specifications of othersSECTION 8 - CANCELLED—
042Research and development services relating to pharmaceutical preparations for human use; pharmaceutical drug development; pharmaceutical formulation testing; pharmaceutical clinical services, namely, basic and clinical research in the field of pharmaceuticalsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 25, 2016C8..CANCELLED SEC. 8 (6-YR)—
Aug 18, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2009NPUBNOTICE OF PUBLICATION—
Apr 28, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 27, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2009ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 5, 2009GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 5, 2009GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 5, 2009CNSISUSPENSION INQUIRY WRITTEN—
Nov 28, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 28, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 28, 2008GNSLLETTER OF SUSPENSION E-MAILED—
May 28, 2008CNSLSUSPENSION LETTER WRITTEN—
May 6, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 5, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 3, 2007GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 3, 2007GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 3, 2007CNSISUSPENSION INQUIRY WRITTEN—
Oct 18, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 18, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Apr 18, 2007CNSLSUSPENSION LETTER WRITTEN—
Apr 3, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2007ALIEASSIGNED TO LIE—
Feb 28, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2006DOCKASSIGNED TO EXAMINER—
Mar 10, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance